Welcome back AI enthusiasts!

In today’s Daily Report:

  • ⚙️AI Agents Transform Software From Tool to Worker

  • 🔬Nvidia Tackles Genomic Research and Drug Discovery

  • 🪨OpenAI’s New BlackRock Board Member

  • 🛠Trending Tools

  • 💰Funding Frontlines

  • 💼Who’s Hiring?

Read Time: 3 minutes

🗞RECENT NEWS

AI TRENDS

⚙️AI Agents Transform Software From Tool to Worker

Image Source: Canva’s AI Image Generators/Magic Media

AI Agents are leading a paradigm shift from Software-as-a-Service (SaaS) to Service-as-Software (SaS).

Key Details:
  • In the SaaS era, companies built software to assist employees with their workflows.

  • For example, Salesforce offers SaaS tools to help sales representatives manage customer interactions to close deals more efficiently.

  • However, these SaaS tools still rely on sales representatives to manually add customer interactions correctly and accurately.

  • Now, SaaS is undergoing a massive transition into SaS with the rise of AI Agents: virtual employees who can think, reason, and adapt to autonomously perform tasks.

  • Instead of just buying a SaaS tool, companies are buying an AI Agent that operates the SaaS tool, handling most of the tasks an employee would.

Why It’s Important:
  • When companies buy SaaS tools like Quickbooks, Salesforce, or HubSpot, they get a resource that boosts an employee’s productivity.

  • SaS handles most of the tasks an employee would, but with greater efficiency and without needing breaks, training, or management.

NVIDIA

🔬Nvidia Tackles Genomic Research and Drug Discovery

Nvidia announced several new partnerships to transform the $10 trillion healthcare and life sciences industry with AI Apps, AI Agents, and AI Systems.

Key Details:
  • Nvidia is collaborating with IQVIA, Illumina, Mayo Clinic, and Arc Institute to advance drug discovery and accelerate genomic breakthroughs.

  • Arc Institute is leveraging NVIDIA H100 Tensor Core GPUs to power the first biological Foundation Model trained on DNA to predict and design genetic sequences.

  • Mayo Clinic is developing AI-powered Digital Pathology with 20 million whole-slide images and 10 million patient records.

Why It’s Important:
  • DNA holds the genetic blueprint for life itself. Understanding how it works enables scientists to develop new drugs and allows doctors to assess a patient’s likelihood of having specific diseases.

  • Instead of examining tissue samples under a microscope, Digital Pathology allows Mayo Clinic to create digital images of tissue samples for remote consultations.

OPENAI

🪨OpenAI’s New BlackRock Board Member

Image Source: CNBC/“OpenAI adds BlackRock exec Adebayo Ogunlesi to board of directors”/Pool/Getty Images/Screenshot

OpenAI recently appointed Adebayo “Bayo” Ogunlesi, a Senior Managing Partner and Chairman of Global Infrastructure Partners at BlackRock, to the company’s Board of Directors (BofD).

Mr. Ogunlesi has experience with expanding a company’s sales and brand awareness into foreign markets. He’ll help OpenAI navigate the global transformation of AI infrastructure to “drive innovation and foster economic growth.”

OpenAI recently raised $6.6 billion, valuing the company at $157 billion. However, the investors required OpenAI to transition the company’s “capped profit” framework into a Delaware Public Benefit Corporation (PBC) that’s no longer controlled by a non-profit BofD.

🩺 PULSE CHECK

Does adding Mr. Ogunlesi to the BofD signal OpenAI’s focus on profit?

Vote Below to View Live Results

Login or Subscribe to participate

🛠TRENDING TOOLS

📊ViableView helps entrepreneurs find profitable niches.

📦Shapen turns text descriptions into richly detailed images.

📱Fullmoon allows you to chat with private, on-device LLMs.

🤝Reachy is an AI Agent that automates outreach on LinkedIn.

⛺️Supascout analyzes App Store reviews to enrich market research.

🔮Browse our always Up-To-Date AI Tools Database.

💰FUNDING FRONTLINES

  • Overhaul lands a $55M Funding Round to help companies fight supply chain theft.

  • Synthesia snaps up a $180M Series D to turn text into videos in minutes.

  • Colossal BioSciences raises a $200M Series C to bring back woolly mammoths.

💼WHO’S HIRING?

  • Netflix (Los Angeles, CA): Data Visualization Intern, Summer 2025

  • Zoetis (Durham, NC): Biodevices Software Test Intern, Summer 2025

  • Neuralink (Fremont, CA): Embedded Software Engineer Intern, Summer 2025

  • NVIDIA (Santa Clara, CA): GPU Performance Architect Intern, Summer 2025

  • Microsoft (Mountain View, CA): Research Intern, Advanced Memory Systems, Summer 2025

🤖PROMPT OF THE DAY

PRICING

🛒Crafting Discount Strategies

You’re an expert Pricing Analyst at [Small Business] with [Product or Service] in [Industry] tasked with crafting discount strategies for [Target Audience] that foster longer-term customer loyalty while meeting [Revenue Goals].

Small Business = [Insert Here]

Product or Service = [Insert Here]

Industry = [Insert Here]

Target Audience = [Insert Here]

Revenue Goals = [Insert Here]

📒FINAL NOTE

FEEDBACK

How would you rate today’s email?

It helps us improve the content for you!

Login or Subscribe to participate

❤️TAIP Review of The Day

“It’s so consistently good!”

-Amanda (1️⃣ 👍Nailed it!)
REFER & EARN

🎉Your Friends Learn, You Earn!

{{rp_personalized_text}}

Refer 3 friends to learn how to 👷‍♀️Build Custom Versions of OpenAI’s ChatGPT.

Copy and paste this link to friends: {{rp_refer_url}}